Comments on: High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany
Crossref DOI link: https://doi.org/10.1007/s00520-019-04886-y
Published Online: 2019-06-03
Published Print: 2020-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cransac, Amélie http://orcid.org/0000-0003-1836-2619
Aho, Serge
Boulin, Mathieu
Text and Data Mining valid from 2019-06-03
Version of Record valid from 2019-06-03
Article History
Received: 20 April 2019
Accepted: 21 May 2019
First Online: 3 June 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.